Search

everythinglearnresearchcommunity

for

Search:↓

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

High-dose interferon is effective for chronic hepatitis C but often causes flu-like symptoms.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Imuvert can prevent some chemotherapy-induced hair loss.

The document corrects errors in previous articles, including a reversed term, updated subject weights, hair count data, and reference numbering.

Verteporfin may improve hair regrowth and reduce scarring after hair transplants.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

The herbal mix of hibiscus and vitex shows promise for treating autoimmune diseases due to its effectiveness and low toxicity.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Ozenoxacin reduces sebum production, helping manage acne.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

OBEME effectively enhances wound healing and could be a promising carrier for skin treatments.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

The committee decided not to approve the drug due to low effectiveness and high risks.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Dovobet ointment used overnight effectively reduces scalp psoriasis severity and itch.

AVT is highly conserved and may have antimicrobial properties.

Some plant extracts may treat livestock diseases, certain animal treatments are safe and effective, but more research on drug safety and resistance is needed.

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.